Adding New Vaccine Type to Leading Immunotherapy Dramatically Reduced Melanoma Recurrence
/PRNewswire/ -- The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when...